Crown Bioscience, Inc. and Horizon Discovery Announce Exclusive Two Year Agreement

News   Apr 03, 2013

 
Crown Bioscience, Inc. and Horizon Discovery Announce Exclusive Two Year Agreement
 
 
 

RELATED ARTICLES

DataArt Joins Biotechnology Association BIO Deutschland

News

Global technology consultancy DataArt announced today that it has joined BIO Deutschland, Germany's biotechnology industry association.

READ MORE

Biomarker for Glioblastoma Predicts Clinical Course and Sensitivity to Treatment

News

Scientists validate a biomarker indicative of patients with Glioblastoma prognosis and likely response to specific therapies.

READ MORE

Biomedical Catalyst Award Goes To BioMoti, Pharmidex and Queen Mary University of London

News

The grant was awarded under the Biomedical Catalyst funding competition to support preclinical studies of new therapeutic approaches for hard-to-treat tumours including advanced ovarian, triple negative breast and pancreatic cancers.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE